SCHEMBL16626541

SCHEMBL16626541

CNCc1cn(S(=O)(=O)c2cncc(F)c2)c2cc(Nc3ccc(F)cc3C)ccc12

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 2/20 0.35
PDE4B Q07343 2/20 0.35
PDE4C Q08493 2/20 0.35
PDE4D Q08499 2/20 0.35
HTR6 P50406 8/20 0.34
LYN P07948 2/20 0.32
BTK Q06187 2/20 0.32
MAPK14 Q16539 2/20 0.32
MAPK13 O15264 1/20 0.32
MAPK12 P53778 1/20 0.32
MAPK11 Q15759 1/20 0.32
SLC6A4 P31645 1/20 0.32
IDE P14735 1/20 0.32
ALDH1A1 P00352 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
ALK Q9UM73 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16618928 0.99 PDE4A (0.35) PDE4APDE4BPDE4CPDE4DHTR6
SCHEMBL16626545 0.90 PDE4A (0.38) PDE4APDE4BPDE4CPDE4DHTR6
SCHEMBL16626417 0.90 ALDH1A1 (0.40) HTR6IDEALDH1A1
Hydrochloric Acid SCHEMBL16619048 0.90 PDE4A (0.38) PDE4APDE4BPDE4CPDE4DHTR6
Hydrochloric Acid SCHEMBL16618639 0.89 ALDH1A1 (0.40) HTR6IDEALDH1A1
SCHEMBL16626727 0.89 PDE4A (0.38) PDE4APDE4BPDE4CPDE4DHTR6
SCHEMBL16626469 0.88 HTR6 (0.44) HTR6MAPK14MAPK13MAPK12MAPK11
Hydrochloric Acid SCHEMBL16618725 0.88 PDE4A (0.38) PDE4APDE4BPDE4CPDE4DHTR6
SCHEMBL16626774 0.88 SLC6A4 (0.36) PDE4APDE4BPDE4CPDE4DHTR6
Hydrochloric Acid SCHEMBL16618684 0.88 HTR6 (0.44) HTR6MAPK14MAPK13MAPK12MAPK11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP claimed
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP disclosed
US-9676714-B2 Sulfonylindole derivatives and method for preparing the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2017-06-13 US disclosed
US-9676714-B2 Sulfonylindole derivatives and method for preparing the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2017-06-13 US disclosed
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2016-08-04 US disclosed
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2016-08-04 US disclosed
WO-2015050412-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2015-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME GIPR, PGC, SI PDE4A 2460/4885PDE4B 1996/4885PDE4C 3748/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.